Stephens Inc. AR increased its stake in CME Group Inc. (NASDAQ:CME) by 10.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,088 shares of the financial services provider’s stock after buying an additional 765 shares during the period. Stephens Inc. AR’s holdings in CME Group were worth $1,013,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of the stock. Riverhead Capital Management LLC increased its stake in CME Group by 4.5% in the 2nd quarter. Riverhead Capital Management LLC now owns 14,332 shares of the financial services provider’s stock worth $1,795,000 after buying an additional 615 shares during the period. Oak Ridge Investments LLC purchased a new position in CME Group in the 2nd quarter worth about $287,000. Northwestern Mutual Wealth Management Co. increased its stake in CME Group by 14.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 9,512 shares of the financial services provider’s stock worth $1,191,000 after buying an additional 1,173 shares during the period. Manitou Investment Management Ltd. increased its stake in CME Group by 3.0% in the 2nd quarter. Manitou Investment Management Ltd. now owns 168,834 shares of the financial services provider’s stock worth $21,145,000 after buying an additional 4,943 shares during the period. Finally, Capital Counsel LLC NY increased its stake in CME Group by 2.1% in the 2nd quarter. Capital Counsel LLC NY now owns 905,323 shares of the financial services provider’s stock worth $113,383,000 after buying an additional 18,628 shares during the period. 82.67% of the stock is currently owned by institutional investors.
WARNING: “CME Group Inc. (CME) Position Lifted by Stephens Inc. AR” was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2017/09/17/cme-group-inc-cme-position-lifted-by-stephens-inc-ar.html.
CME has been the topic of a number of research reports. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Jefferies Group LLC reissued a “buy” rating and set a $128.00 target price on shares of CME Group in a research report on Monday, July 10th. UBS AG reissued a “buy” rating and set a $135.00 target price (up previously from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Keefe, Bruyette & Woods reissued a “hold” rating and set a $127.00 target price on shares of CME Group in a research report on Friday, July 14th. Finally, Citigroup Inc. initiated coverage on shares of CME Group in a research report on Wednesday, July 12th. They set a “buy” rating and a $140.00 target price on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $132.56.
In related news, Chairman Terrence A. Duffy sold 21,815 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The shares were sold at an average price of $123.89, for a total transaction of $2,702,660.35. Following the sale, the chairman now directly owns 110,711 shares in the company, valued at $13,715,985.79. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Dennis Suskind sold 750 shares of the company’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $129.34, for a total transaction of $97,005.00. Following the sale, the director now owns 5,059 shares in the company, valued at $654,331.06. The disclosure for this sale can be found here. Insiders have sold 48,244 shares of company stock worth $6,021,890 over the last 90 days. Insiders own 0.57% of the company’s stock.
CME Group Inc. (NASDAQ:CME) opened at 131.29 on Friday. The stock has a market cap of $44.63 billion, a P/E ratio of 26.80 and a beta of 0.72. The stock has a 50 day moving average of $126.18 and a 200-day moving average of $122.07. CME Group Inc. has a 12 month low of $98.95 and a 12 month high of $132.34.
CME Group (NASDAQ:CME) last released its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.03. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The firm had revenue of $925.00 million for the quarter, compared to analyst estimates of $931.05 million. During the same period in the prior year, the firm earned $1.14 earnings per share. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities analysts forecast that CME Group Inc. will post $4.81 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be paid a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 2.01%. CME Group’s payout ratio is 53.99%.
CME Group Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.